Literature DB >> 15819430

A cohabitation challenge to compare the efficacies of vaccines for bacterial kidney disease (BKD) in chinook salmon Oncorhynchus tshawytscha.

Stewart Alcorn1, Anthony L Murray, Ronald J Pascho, Jed Varney.   

Abstract

The relative efficacies of 1 commercial and 5 experimental vaccines for bacterial kidney disease (BKD) were compared through a cohabitation waterborne challenge. Groups of juvenile chinook salmon Oncorhynchus tshawytscha were vaccinated with one of the following: (1) killed Renibacterium salmoninarum ATCC 33209 (Rs 33209) cells; (2) killed Rs 33209 cells which had been heated to 37 degrees C for 48 h, a process that destroys the p57 protein; (3) killed R. salmoninarum MT239 (Rs MT239) cells; (4) heated Rs MT239 cells; (5) a recombinant version of the p57 protein (r-p57) emulsified in Freund's incomplete adjuvant (FIA); (6) the commercial BKD vaccine Renogen; (7) phosphate-buffered saline (PBS) emulsified with an equal volume of FIA; or (8) PBS alone. Following injection, each fish was marked with a subcutaneous fluorescent latex tag denoting its treatment group and the vaccinated fish were combined into sham and disease challenge tanks. Two weeks after these fish were vaccinated, separate groups of fish were injected with either PBS or live R. salmoninarum GL64 and were placed inside coated-wire mesh cylinders (liveboxes) in the sham and disease challenge tanks, respectively. Mortalities in both tanks were recorded for 285 d. Any mortalities among the livebox fish were replaced with an appropriate cohort (infected with R. salmoninarum or healthy) fish. None of the bacterins evaluated in this study induced protective immunity against the R. salmoninarum shed from the infected livebox fish. The percentage survival within the test groups in the R. salmoninarum challenge tank ranged from 59% (heated Rs MT239 bacterin) to 81% (PBS emulsified with FIA). There were no differences in the percentage survival among the PBS-, PBS/FIA-, r-p57- and Renogen-injected groups. There also were no differences in survival among the bacterin groups, regardless of whether the bacterial cells had been heated or left untreated prior to injection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15819430     DOI: 10.3354/dao063151

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  3 in total

1.  Both msa genes in Renibacterium salmoninarum are needed for full virulence in bacterial kidney disease.

Authors:  Alison M Coady; Anthony L Murray; Diane G Elliott; Linda D Rhodes
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

2.  Nutritional immunomodulation of Atlantic salmon response to Renibacterium salmoninarum bacterin.

Authors:  Mohamed Emam; Khalil Eslamloo; Albert Caballero-Solares; Evandro Kleber Lorenz; Xi Xue; Navaneethaiyer Umasuthan; Hajarooba Gnanagobal; Javier Santander; Richard G Taylor; Rachel Balder; Christopher C Parrish; Matthew L Rise
Journal:  Front Mol Biosci       Date:  2022-09-21

3.  Atlantic Salmon Pre-smolt Survivors of Renibacterium salmoninarum Infection Show Inhibited Cell-Mediated Adaptive Immune Response and a Higher Risk of Death During the Late Stage of Infection at Lower Water Temperatures.

Authors:  Marco Rozas-Serri; Carlos Lobos; Rodolfo Correa; Ricardo Ildefonso; Jorge Vásquez; Ariel Muñoz; Lucerina Maldonado; Victoria Jaramillo; Darling Coñuecar; Camila Oyarzún; Romina Walker; Carolina Navarrete; Jorge Gayosa; Patricio Mancilla; Andrea Peña; Carolina Senn; Francisco Schwerter
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.